352 related articles for article (PubMed ID: 35669282)
1. Network Pharmacology-Based Strategy Combined with Molecular Docking and in vitro Validation Study to Explore the Underlying Mechanism of Huo Luo Xiao Ling Dan in Treating Atherosclerosis.
Sun T; Quan W; Peng S; Yang D; Liu J; He C; Chen Y; Hu B; Tuo Q
Drug Des Devel Ther; 2022; 16():1621-1645. PubMed ID: 35669282
[TBL] [Abstract][Full Text] [Related]
2. A computational and functional study elicits the ameliorating effect of the Chinese herbal formula Huo Luo Xiao Ling Dan on experimental ischemia-induced myocardial injury in rats via inhibition of apoptosis.
Han XD; Zhou ZW; Yang W; Ye HC; Xu YZ; Huang YF; Zhang T; Zhou SF
Drug Des Devel Ther; 2015; 9():1063-102. PubMed ID: 25733819
[TBL] [Abstract][Full Text] [Related]
3. Network Pharmacology Prediction and Molecular Docking-Based Strategy to Discover the Potential Pharmacological Mechanism of Huai Hua San Against Ulcerative Colitis.
Liu J; Liu J; Tong X; Peng W; Wei S; Sun T; Wang Y; Zhang B; Li W
Drug Des Devel Ther; 2021; 15():3255-3276. PubMed ID: 34349502
[TBL] [Abstract][Full Text] [Related]
4. Network Pharmacology-Based Prediction and Verification of the Active Ingredients and Potential Targets of Zuojinwan for Treating Colorectal Cancer.
Huang S; Zhang Z; Li W; Kong F; Yi P; Huang J; Mao D; Peng W; Zhang S
Drug Des Devel Ther; 2020; 14():2725-2740. PubMed ID: 32764874
[TBL] [Abstract][Full Text] [Related]
5. Molecular targets and mechanisms of Guanxinning tablet in treating atherosclerosis: Network pharmacology and molecular docking analysis.
Niu C; Zhang P; Zhang L; Lin D; Lai H; Xiao D; Liu Y; Zhuang R; Li M; Ma L; Ye J; Pan Y
Medicine (Baltimore); 2023 Sep; 102(39):e35106. PubMed ID: 37773840
[TBL] [Abstract][Full Text] [Related]
6. Potential active compounds and molecular mechanism of Xuefu Zhuyu decoction for atherosclerosis, based on network pharmacology and molecular docking.
Li Y; Liu B; Liu L; Xu Q; Shen Q; Li W; Zhao J
Medicine (Baltimore); 2022 Aug; 101(32):e29654. PubMed ID: 35960089
[TBL] [Abstract][Full Text] [Related]
7. Network Pharmacology and Molecular Docking Study on the Potential Mechanism of Yi-Qi-Huo-Xue-Tong-Luo Formula in Treating Diabetic Peripheral Neuropathy.
Lin Y; Shen C; Wang F; Fang Z; Shen G
J Diabetes Res; 2021; 2021():9941791. PubMed ID: 34159207
[TBL] [Abstract][Full Text] [Related]
8. Network pharmacology-based prediction and verification of the active ingredients and potential targets of Huagan Decoction for reflux esophagitis.
Zhao Y; Cao Y; Yang X; Guo M; Wang C; Zhang Z; Zhang Q; Huang X; Sun M; Xi C; Tangthianchaichana J; Bai J; Du S; Lu Y
J Ethnopharmacol; 2022 Nov; 298():115629. PubMed ID: 35988839
[TBL] [Abstract][Full Text] [Related]
9. Molecular mechanisms of Huanglian Jiedu decoction in treating Alzheimer's disease by regulating microbiome
Zheng R; Shi S; Zhang Q; Yuan S; Guo T; Guo J; Jiang P
Front Cell Infect Microbiol; 2023; 13():1140945. PubMed ID: 37009506
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms underlying the synergistic effects of chuanxiong combined with Chishao on treating acute lung injury based on network pharmacology and molecular docking combined with preclinical evaluation.
Gao J; Wang N; Song W; Yuan Y; Teng Y; Liu Z
J Ethnopharmacol; 2024 May; 325():117862. PubMed ID: 38342157
[TBL] [Abstract][Full Text] [Related]
11. A network pharmacology approach and experimental validation to investigate the anticancer mechanism of Qi-Qin-Hu-Chang formula against colitis-associated colorectal cancer through induction of apoptosis via JNK/p38 MAPK signaling pathway.
Wu Y; Fang Y; Li Y; Au R; Cheng C; Li W; Xu F; Cui Y; Zhu L; Shen H
J Ethnopharmacol; 2024 Jan; 319(Pt 3):117323. PubMed ID: 37852337
[TBL] [Abstract][Full Text] [Related]
12. Identification of bioactive compounds and potential mechanisms of scutellariae radix-coptidis rhizoma in the treatment of atherosclerosis by integrating network pharmacology and experimental validation.
Ji L; Song T; Ge C; Wu Q; Ma L; Chen X; Chen T; Chen Q; Chen Z; Chen W
Biomed Pharmacother; 2023 Sep; 165():115210. PubMed ID: 37499457
[TBL] [Abstract][Full Text] [Related]
13. Potential Molecular Mechanisms of Ephedra Herb in the Treatment of Nephrotic Syndrome Based on Network Pharmacology and Molecular Docking.
Yao T; Wang Q; Han S; Lu Y; Xu Y; Wang Y
Biomed Res Int; 2022; 2022():9214589. PubMed ID: 35837376
[TBL] [Abstract][Full Text] [Related]
14. Exploration of the possible mechanisms of Ling Gui Zhu Gan decoction in nephrotic syndrome based on network pharmacology, molecular docking and molecular dynamics simulation.
Shi L; Deng Y; Luo D; Li L; Kuang X; Qi A; Fu B
Medicine (Baltimore); 2023 Jul; 102(29):e34446. PubMed ID: 37478256
[TBL] [Abstract][Full Text] [Related]
15. Network Pharmacology and Molecular Docking-Based Investigation of Potential Targets of Astragalus membranaceus and Angelica sinensis Compound Acting on Spinal Cord Injury.
Cao S; Hou G; Meng Y; Chen Y; Xie L; Shi B
Dis Markers; 2022; 2022():2141882. PubMed ID: 36157206
[TBL] [Abstract][Full Text] [Related]
16. Arachidonic acid metabonomics study for understanding therapeutic mechanism of Huo Luo Xiao Ling Dan on rat model of rheumatoid arthritis.
Wang N; Zhao X; Huai J; Li Y; Cheng C; Bi K; Dai R
J Ethnopharmacol; 2018 May; 217():205-211. PubMed ID: 29474901
[TBL] [Abstract][Full Text] [Related]
17. Study on the Potential Mechanism of Tonifying Kidney and Removing Dampness Formula in the Treatment of Postmenopausal Dyslipidemia Based on Network Pharmacology, Molecular Docking and Experimental Evidence.
Li X; Chen H; Yang H; Liu J; Li Y; Dang Y; Wang J; Wang L; Li J; Nie G
Front Endocrinol (Lausanne); 2022; 13():918469. PubMed ID: 35872979
[TBL] [Abstract][Full Text] [Related]
18. Exploring the mechanism of Ginkgo biloba L. leaves in the treatment of vascular dementia based on network pharmacology, molecular docking, and molecular dynamics simulation.
Pan J; Tang J; Gai J; Jin Y; Tang B; Fan X
Medicine (Baltimore); 2023 May; 102(21):e33877. PubMed ID: 37233418
[TBL] [Abstract][Full Text] [Related]
19. Network pharmacology-based prediction and validation of the active ingredients and potential mechanisms of the Huangxiong formula for treating ischemic stroke.
Zhao S; Zhang P; Yan Y; Xu W; Li J; Wang L; Wang N; Huang Y
J Ethnopharmacol; 2023 Aug; 312():116507. PubMed ID: 37080367
[TBL] [Abstract][Full Text] [Related]
20. Comparative pharmacokinetic study of two boswellic acids in normal and arthritic rat plasma after oral administration of Boswellia serrata extract or Huo Luo Xiao Ling Dan by LC-MS.
Wang H; Zhang C; Wu Y; Ai Y; Lee DY; Dai R
Biomed Chromatogr; 2014 Oct; 28(10):1402-8. PubMed ID: 24806456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
